Gsa Capital Partners LLP Magenta Therapeutics, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$0.97 - $3.08 $41,382 - $131,398
-42,662 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$2.55 - $5.23 $35,529 - $72,869
13,933 Added 48.5%
42,662 $124,000
Q4 2021

Feb 14, 2022
BUY
$4.43 - $8.33 $127,269 - $239,312
28,729 New
28,729 $127,000

Others Institutions Holding MGTA

# of Institutions
2
Shares Held
442K
Call Options Held
0
Put Options Held
0
View Full List

About Magenta Therapeutics, Inc.

MGTA Quotes by TradingView
  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email